These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4317690)

  • 1. Intracerebral infection of mice with high-virulence and low-virulence strains of Bordetella pertussis.
    Adams GJ
    J Med Microbiol; 1970 Feb; 3(1):1-13. PubMed ID: 4317690
    [No Abstract]   [Full Text] [Related]  

  • 2. An electron-microscope study of intracerebral infection of mice with low-virulence Bordetella pertussis.
    Hopewell JW; Holt LB; Desombre TR
    J Med Microbiol; 1972 Feb; 5(1):154-7. PubMed ID: 4336736
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of intracerebral infection of mice with Bordetella pertussis.
    Adams GJ; Hopewell JW
    J Med Microbiol; 1970 Feb; 3(1):15-27. PubMed ID: 4317688
    [No Abstract]   [Full Text] [Related]  

  • 4. An electron-microscopic study of intracerebral infection of mice with low-virulence Bordetella pertussis.
    Hopewell JW; Desombre TR; Holt LB
    J Med Microbiol; 1972 Nov; 5(4):P18. PubMed ID: 4345768
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on phase variation in Bordetella pertussis.
    Goldman S; Hanski E; Fish F
    Dev Biol Stand; 1985; 61():255-64. PubMed ID: 2872111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An electron-microscope study of intracerebral infection of mice with low-virulence Bordetella pertussis.
    Hopewell JW; Desombre TR; Holt LB
    J Pathol; 1972 Jul; 107(3):Pvi. PubMed ID: 4343581
    [No Abstract]   [Full Text] [Related]  

  • 7. Bordetella pertussis binds human C1 esterase inhibitor during the virulent phase, to evade complement-mediated killing.
    Marr N; Luu RA; Fernandez RC
    J Infect Dis; 2007 Feb; 195(4):585-8. PubMed ID: 17230419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine model for pertussis vaccine encephalopathy: role of the major histocompatibility complex; antibody to albumin and to Bordetella pertussis and pertussis toxin.
    Steinman L; Weiss A; Adelman N; Lim M; Oehlert J; Zuniga R; Hewlett E; Falkow S
    Dev Biol Stand; 1985; 61():439-46. PubMed ID: 2872126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of differential virulence gene promoter activation in vivo in Bordetella pertussis using RIVET.
    Veal-Carr WL; Stibitz S
    Mol Microbiol; 2005 Feb; 55(3):788-98. PubMed ID: 15661004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic structure and phase variation in Bordetella pertussis.
    Nakase Y; Takatsu K; Kasuga T
    Jpn J Microbiol; 1969 Sep; 13(3):283-91. PubMed ID: 4310290
    [No Abstract]   [Full Text] [Related]  

  • 11. [The interrelation of the composition of the nutrient media with the growth and biological properties of Bordetella pertussis].
    Stepanshina VN; Alekseeva LN; Korobova OV; Logacheva LV; Shepelin AP; Anisimov GA; Volkovoĭ KI
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):26-7. PubMed ID: 7879517
    [No Abstract]   [Full Text] [Related]  

  • 12. Virulence of a Bordetella pertussis strain expressing a mutant adenylyl cyclase with decreased calmodulin affinity.
    Oldenburg DJ; Gross MK; Smith AL; Storm DR
    Microb Pathog; 1993 Jun; 14(6):489-93. PubMed ID: 8412621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses.
    Fennelly NK; Sisti F; Higgins SC; Ross PJ; van der Heide H; Mooi FR; Boyd A; Mills KH
    Infect Immun; 2008 Mar; 76(3):1257-66. PubMed ID: 18195025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A commentary on the pathogenesis of pertussis.
    Hewlett EL
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S94-8. PubMed ID: 10447025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selection of Bvg- variants of Bordetella pertussis].
    Passerini de Rossi BN; Friedman LE; Darnaud S; de Torres RA; Franco MA
    Rev Argent Microbiol; 1997; 29(2):75-83. PubMed ID: 9424628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of growth conditions on adenylate cyclase activity and virulence-related properties of Bordetella pertussis.
    Brownlie RM; Parton R; Coote JG
    J Gen Microbiol; 1985 Jan; 131(1):17-25. PubMed ID: 2859346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth idiosyncrasies of some Bordetella pertussis strains, and the intracerebral virulence of these strains in mice.
    BROWN AM
    J Gen Microbiol; 1959 Jun; 20(3):532-9. PubMed ID: 13664900
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of Bordetella pertussis strains toxicity in vitro using CHO cell lines].
    Zawadka M; Rabczenko D; Lutyńska A
    Med Dosw Mikrobiol; 2014; 66(3-4):185-94. PubMed ID: 25804072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BapC autotransporter protein is a virulence determinant of Bordetella pertussis.
    Noofeli M; Bokhari H; Blackburn P; Roberts M; Coote JG; Parton R
    Microb Pathog; 2011 Sep; 51(3):169-77. PubMed ID: 21554944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental models for testing "Bordetella pertussis" virulence and immunogenicity.
    Alonso JM; Rocancourt M; Le Nin S; Brezin C
    Ann Sclavo Collana Monogr; 1986; 3(1-2):319-27. PubMed ID: 2892512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.